Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cyclacel Pharmaceuticals Q2 EPS $(0.56) Misses $(0.50) Estimate

Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.50) by 12 percent. This is a 3.45 percent increase over losses of $(0.58) per share
byBenzinga Newsdesk
August 11, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.50) by 12 percent. This is a 3.45 percent increase over losses of $(0.58) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts